In mammalian cells, the signal recognition particle (SRP) receptor is required for the targeting of nascent secretory proteins to the endoplasmic reticulum (ER) membrane. We have identified the Saccharomyces cerevisiae homologue of the a-subunit of the SRP receptor (SRa) and characterized its function in vivo. S. cerevisiae SRa is a 69-kDa peripheral membrane protein that is 32% identical (54% chemically similar) to its mammalian homologue and, like mammalian SRa, is predicted to contain a GTP binding domain. Yeast cells that contain the SRa gene (SRP1O1) under control of the GALl promoter show impaired translocation of soluble and membrane proteins across the ER membrane after depletion of SRa. The degree of the translocation defect varies for different proteins. The defects are similar to those observed in SRP deficient cells. Disruption of the SRPIO gene results in an approximately sixfold reduction in the growth rate of the cells. Disruption of the gene encoding SRP RNA (SCRI) or both SCRI and SRP101 resulted in an indistinguishable growth phenotype, indicating that SRP receptor and SRP function in the same pathway. Taken together, these results suggest that the components and the mechanism of the SRP-dependent protein targeting pathway are evolutionarily conserved yet not essential for cell growth. Surprisingly, cells that are grown for a prolonged time in the absence of SRP or SRP receptor no longer show pronounced protein translocation defects. This adaptation is a physiological process and is not due to the accumulation of a suppressor mutation. The degree of this adaptation is strain dependent.
INTRODUCTION
Mammalian signal recognition particle (SRP)1 acts to target ribosomes that synthesize secretory and membrane proteins to the endoplasmic reticulum (ER) membrane where they are translocated across the membrane into the ER lumen. In vitro assays have allowed the development of a detailed model describing the function of SRP in mammalian cells (Walter and Lingappa, 1986, for review) . In brief, signal sequences that are expressed 'Abbreviations used: bp, base pair; CPY, carboxypeptidase Y; DPAP-B, dipeptidyl aminopeptidase-B; DTT, dithiothreitol; ER, endoplasmic reticulum; HEPES, N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid; kb, kilobase; PCR, polymerase chain reaction; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SRa, SRP receptor a-subunit; SRf3, SRP receptor d-subunit; SRP, signal recognition particle; SRP54, 54-kDa subunit of SRP; Tris, tris-(hydroxymethyl)aminomethane.
as part of a nascent protein chain emerging from the ribosome bind to SRP in a binding site contained on the 54-kDa SRP subunit (SRP54) (Krieg et al., 1986; Kurzchalia et al., 1986) . This interaction causes SRP to bind tightly to the ribosome, effecting an elongation arrest or pause in the translation of the nascent secretory protein. Interaction of the engaged SRP with the SRP receptor, a heterodimeric membrane protein, that is anchored in the ER membrane (Gilmore et al., 1982a; Meyer et al., 1982; Tajima et al., 1986) releases the translational arrest and allows the ribosome that is synthesizing the protein chain to become bound to other components in the ER membrane. These components, collectively termed a "translocon," allow the transfer of the growing protein chain across the membrane, presumably through a transient aqueous pore in the membrane (Gilmore and Blobel, 1985; Simon and Blobel, 1991) . SRP and SRP receptor act catalytically in this process; they are not part of the ribosome-membrane junction that mediates the transfer of the protein chain across the lipid bilayer. Rather, they function to bring the ribosome to the correct target membrane and are then released from the ribosome (Gilmore and Blobel, 1983) .
Interestingly, SRP54 and the a-subunit of the SRP receptor (SRa) both contain a GTPase domain (G-domain) (Bernstein et al., 1989; Connolly and Gilmore, 1989; Romisch et al., 1989) . The G-domains of SRP54 and SRa are homologous to one another and define a new family of GTPases. The fl-subunit of the SRP receptor (SRfl) also contains a GTPase domain, which is structurally distinct from those of SRP54 and SRa (Miller and Walter, unpublished data) . The precise mechanistic role of each of the three GTPase domains that interact during the SRP-dependent protein targeting reaction remains to be elucidated. Cycles of GTP hydrolysis by SRP54 and SRP receptor may control the assembly of the SRP-signal sequence-ribosome complex and the assembly of components of the translocon. Thus, GTP hydrolysis may enhance the fidelity of and provide unidirectionality to the targeting reaction. Point mutations in the GTP binding sites of SRP54 and SRa block the translocation of proteins across the ER membrane (Rapiejko and Gilmore, 1992; Bernstein and Walter, unpublished data) , indicating that both GTP binding sites are functionally important in the pathway.
Recently, components of a SRP have been identified and characterized in Saccharomyces cerevisiae (Hann and Walter, 1991; Hann et al., 1992; Stirling and Hewitt, 1992) . The yeast SRP is a 16S cytoplasmic ribonucleoprotein that is important for the targeting of membrane and secretory proteins to the ER membrane. S. cerevisiae SRP is not essential for cell growth, although cells in which SRP is genetically disrupted grow poorly. The translocation of a number of soluble and membrane proteins into the lumen of the ER is impaired in SRP deficient cells. Surprisingly, different proteins show translocation defects of varying severity. After SRP depletion, the membrane integration of dipeptidyl aminopeptidase B (DPAP-B) is inhibited by over 90%, the translocation of preKAR2p is inhibited by -50%, and the translocation of preprocarboxypeptidase Y (preproCPY) is not affected. Thus, in the absence of SRP, proteins are targeted via an SRP-independent pathway to the ER membrane and are translocated in sufficient amounts to sustain cell growth. Some proteins, however, cannot efficiently use the SRP-independent pathway.
The approach that lead to the first identification of the yeast SRP took advantage of the phylogenetic conservation of the primary structure of the mammalian SRP54 and its prokaryotic homologue, the product of the ffh gene of Escherichia coli. Comparison of these evolutionary distant sequences allowed the identification of conserved blocks of amino acids that were used in a polymerase chain reaction (PCR)-based approach to isolate the gene (SRP54) encoding the corresponding protein from S. cerevisiae (Hann et al., 1989 ). Here we have used a similar method to identify an SRa homologue in S. cerevisiae.
MATERIALS AND METHODS

Strains, Antibodies, and General Methods
Yeast strains used in this study are listed in Table 1 . Genetic techniques were performed as described by Sherman et al. (1974) , except where noted. Anti-DPAP-B serum was kindly provided by Tom Stevens, Institute of Molecular Biology, University of Oregon, Eugene; antiKAR2p by Mark Rose, Biology Department, Princeton University, Princeton, NJ; anti-invertase, anti-CPY, anti-Sec6lp, and anti-preproa-factor by Randy Schekman, Division of Biochemistry and Molecular Biology, University of California at Berkeley; and anti-F,,BATPase by M. Yaffe, Department of Biology, University of California, San Diego.
Recombinant DNA techniques were performed as described in Maniatis et al. (1982) . Oligonucleotides were synthesized on a Milligen/ Biosearch Cyclone Plus DNA synthesizer (Milligen/Biosearch, Division of Millipore, Novato, CA) and purified according to the manufacturer's instructions. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed on 10-15% gradient gels and all Western blots were visualized by enhanced chemiluminescence (Amersham, Arlington Heights, IL) according to the inStructions of the manufacturer.
PCR and Cloning of SRP101
PCR was performed on S. cerevisiae genomic DNA as described (Saiki et al., 1988; Hann et al., 1989; Kamb et al., 1989) . The oligonucleotide "A" had the sequence 5'-GGTGTNAA(T/C)GGNGTNGGNAA-3' (20mer, 512-fold degenerate) and encoded the amino acid sequence GVNGVGK. The reverse complement of oligonucleotide "B" with the sequence 5'-CN(G/C)CNGCNC(G/T)(A/G)AANGT(A/G)TC-3' (20mer, 4096-fold degenerate) encoded the amino acids DTFRAGA (Hann et al., 1989) . PCR products were separated on a 6% polyacrylamide gel. A 110-base pair (bp) band was excised from the gel and sequenced as described by Hann et al. (1989) .
A genomic clone of the SRP101 gene was isolated by screening a plasmid library of S. cerevisiae strain AB320 (Nasmyth and Tatchell, 1980) in the vector YEp13 using either the gel purified S. cerevisiae PCR product or, in later rounds of screening, an oligonucleotide derived from the PCR sequence. The complete 4.6-kilobase (kb) genomic insert together with flanking (pBR322 derived) vector sequences was excised by digestion with EcoRI and Sal I and cloned into Bluescript II SK (+) and SK (-) (Stratagene, La Jolla, CA) to generate plasmids pSRP101(+) and pSRP101(-), respectively. A series of deletions from the 5' end of the insert was generated using the method of Henikoff (1984) (using the Stratagene Exo-Mung kit) for the pSRP101(+) clone (Henikoff, 1984) ; a series of deletions from the 3' end was generated using the Kilo-sequencing method of Barnes (1987) for the pSRP101 (-) clone (Barnes, 1987) . Dideoxysequencing using Sequenase (United States Biochemicals, Cleveland, OH), 35S-dATP, and electrolyte gradient gels (Sheen and Seed, 1988) was carried out on single stranded phagemid DNA isolated according to Stratagene protocols. Gaps in the sequence were filled by sequencing from synthetic oligonucleotide primers. Base number 1 of the DNA sequence deposited in Genbank (accession no. M77274) is the A of the presumptive initiating AUG codon.
Gene Disruption and Rescue
We constructed a DNA fragment suitable for gene disruption of the SRP1O1 locus by PCR. A 2320-bp DNA fragment of the ADE2 locus (bases 273-2593 [Stotz and Linder, 1990] ) was amplified by PCR using two primers that each contained 27 bases of ADE2 sequence at their SRP Receptor in Yeast 3' ends (bases 273-300 and 2566-2593 of the ADE2 sequence [Stotz and Linder, 1990] ) and 72 bases of SRP101 sequence at their 5' ends (bases -1 to -72 and 1780-1846 of the SRP1I01 sequence [ Figure 5A ]), respectively. The resulting 2474-bp fragment was introduced into an ade2 diploid strain (strain W303) by one step gene replacement (OrrWeaver et al., 1981) using the LiOAc transformation procedure (Ito et al., 1983) . Yeast genomic DNA was prepared (Davis et al., 1980) from Ade+ transformants and was screened by PCR using oligonucleotides corresponding to bases -404 to -385 and 2136-2153 ( Figure  5A , regions Y and Z) of the SRPIOI locus. The ADE2 gene was found to be correctly integrated at the SRP101 locus in 1 of 16 isolated Ade+ transformants.
Disruption of the SCRI gene was performed exactly as in Hann and Walter (1991) , except that the W303 strain was used. The disruption was confirmed by Southern hybridization as described (Hann and Walter, 1991) . Because loss of either SCR1 or SRPIOI yields only rhocells, a diploid heterozygote resulting from a cross of these two deletions is also rho-and, consequently, unable to sporulate. Thus, we could not construct a strain bearing the double deletion of SCR1 and SRP1O1 by crossing strains bearing the single deletions. The double deletion was therefore constructed by the following procedure. A rhohaploid strain (SOY60, but MATa) containing scrl-A2 (SCR1::HIS3) was crossed with a rho' strain (SOY48) containing srplOl-Al (SRP101: .ADE2) complemented by plasmid pSO210 (see below). After selection on His-, Ade-, Ura-plates, diploids were scored for loss of pSO210 by growth on plates containing 5-fluoroorotic acid. The resulting diploid, heterozygous for both gene deletions, was sporulated and dissected by standard procedures.
Rescue of the haploid strain containing the SRPO1I deletion (srplOlAl) was performed by moving the complete genomic SRa insert of plasmid pSRP101(+) on a 7.0-kb Pvu I fragment into the CEN6ARS4-containing Pvu I fragment of plasmids pRS316 and pRS314 (Sikorski and Heiter, 1989) to yield plasmids pSO210 and pS0220, respectively. Plasmid pSO210 contains URA3 as a selectable marker, and pS0220 contains TRP1 as a marker. These plasmids were transformed into the SRP101/srplOl-A1 diploid strain SOY34 by selecting for Ura+ or Trp+ transformants. Transformants were sporulated and tetrads dissected and tested by standard procedures (Sherman et al., 1974) .
Preparation of Antibodies to SRae
Antiserum was raised against a fusion protein expressed in E. coli, containing glutathione-S-transferase from S. Japonicum as the N-terminal domain linked to a fragment of SRa. This fusion protein was generated by a three step subcloning procedure. First, pUC5'A242 was generated by subcloning a 2.0-kb Xba I-HindIII fragment from pSRP101(+) encoding the C-terminal 379 amino acids of SRPI01 into the Xba I-HindIll sites of pUC18. Second, pUCSRP101 was constructed by subcloning a 740-bp PCR fragment encoding the first 242 amino acids of SRP101 into the BamHI-Xba I site of pUC5'A242. This regenerated the entire coding sequence of SRP101 and removed all the DNA sequence information upstream of the start codon. Finally, subcloning a 950-bp BamHI-HpaI fragment from pUCSRP101 into the BamHI-EcoRI site of pGEX-3X created the fusion protein plasmid, pGEXSRP101 (Smith and Johnson, 1988) .
A 60-kDa fusion protein, containing amino acids 1-317 from SRa, was overproduced in E. coli. The protein was insoluble and was therefore solubilized in urea before further purification by differential centrifugation and preparative SDS-PAGE (Schloss et al., 1988) . Polyclonal rabbit antiserum against the SDS denatured fusion protein was prepared by Caltag (South San Francisco, CA).
The antibodies were purified by affinity chromatography. The fusion protein was coupled to CNBr activated Sepharose Cl-4B (Pharmacia, Piscataway, NJ) at a concentration of 6 mg/ml according to the manufacturers instructions. Bound antibodies were eluted as described (Walter and Blobel, 1983) . Affinity purified antibodies were concentrated by precipitation with ammonium sulfate, resuspended in phosphate-buffered saline containing 50% glycerol and 0.02% NaN3 at a concentration of 4 mg/ml, and stored at -80°C.
Cell Fractionation
Subcellular localization of SRa was performed essentially as in Deshaies and Schekman (1990) . Briefly, strain W303 was grown to 2.0 OD600/ml, and cells were harvested by centrifugation in a clinical centrifuge. After one wash in buffer A (100 mM tris(hydroxymethyl)aminomethane [Tris]-HCl, pH 9.4, 10 mM dithiothreitol (DTT), 10 mM NaN3), cells were resuspended to a concentration of 20 OD600 cell equivalents per ml in buffer A and incubated for 10 min at 24°C. Cells were then pelleted and resuspended in spheroplast buffer (25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES]/KOH, pH 7.5, 20 mM DTT, 5 mM MgCl2, 10 mM NaN3) containing 1.3 M sorbitol to a concentration of 50 OD600 cell equivalents/ml. After adding 25 U/OD600 of lyticase (Sigma Chemicals, St. Louis, MO), cells were incubated with shaking at 30°C for 30 min. Spheroplasts were centrifuged through a cushion consisting of spheroplast buffer without DTT containing 1.9 M sorbitol at 8000 X g (7250 rpm) in a Beckman (Fullerton, CA) JS-13 rotor for 5 min at 4°C.
Spheroplasts were resuspended in lysis buffer (200 mM sorbitol, 10 mM HEPES-KOH, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 2 jig/ml each of the protease inhibitors pepstatin A, leupeptin, chymostatin, and antipain) to a concentration of 100 OD600 cell equivalents/ml. Lysis of the cells was achieved by gently vortexing (setting 3 on a scale of 1 to 10) the cell suspension three times in the presence of three-fourths volume zirconium oxide beads (Biospec Products, Bartlesville, OK). Each round of lysis consisted of 15 s of vortexing followed by 30 s incubation at 40C.
The supematant fraction was transferred to a new tube, and the beads were washed one time with one volume of lysis buffer. The supematant and wash fractions were combined and adjusted to a final concentration of the cell lysate of 50 OD600 cell equivalents/ml. The cell lysate was subjected to a low-speed centrifugation of 200 X g (1200 rpm) in a Beckman JS-13 rotor for 4 min at 4°C.
The resulting supematant fraction was further fractionated by centrifugation in a Beckman TL100 ultracentrifuge at 96 600 X g (50 000 rpm) in a TLA100 rotor for 25 min at 4°C. Mock extraction of the low-speed supernatant fraction was performed by addition of one fifth of the final volume of lysis buffer, incubation at 4°C for 20 min, and separation into pellet and supernatant fractions by centrifugation at 96 600 X g as described above. Extraction of the low-speed supernatant was performed by the addition of one fifth of the final volume of either 8 M urea, 3 M KOAc, or 2.5% Triton X-100. Samples were incubated for 20 min at 4°C and then separated into pellet and supematant fractions by centrifugation at 96 600 X g. Sodium carbonate extraction was performed by the addition of the low-speed supematant to 100 volumes of ice-cold 100 mM Na2CO3 (pH 11.5), incubation at 4°C for 30 min, and separation into pellet and supematant fractions by centrifugation at 103 040 X g (50 000 rpm) in a Beckman TLA100.2 rotor.
Conditional Expression of SRP101
The plasmid pS0400 that contains SRPIOI under the control of the GALI promoter was produced by a two-step subcloning procedure. A 2.6-kb BamHI-HindIII fragment from pUCSRP101 (containing the entire coding sequence of SRP101 but lacking all of the 5' control region; see above for construction details) was subcloned into the BamHI-HindIII site of pRS316 (Sikorski and Heiter, 1989) , generating plasmid pSO213. In a second step, a 685-bp BamHI fragment containing the GALl promoter was inserted into the BamHI site of pSO213, generating the plasmid pS0400. The GALI shut-off, 35S-methionine labeling, and denaturing immunoprecipitations were performed as described in Hann and Walter (1991) .
Protease Protection Assay and Pulse-Chase Analysis Protease protections were performed essentially as described by Deshaies and Schekman (1990) . S. cerevisiae strain SOY46 and control cells were metabolically labeled for 7 min with 35S-methionine after (Bernstein et al., 1989; R6misch et al., 1989) . These sequences allowed us to design oligonucleotide probes that could be used in PCR to identify genes encoding putative SRa homologues in yeast. For this purpose, we synthesized two pools of degenerate oligonucleotides. One pool encoded a seven amino acid stretch (designated A in Figure 1 ) that is conserved between mammalian SRa and FtsY but distinct from eukaryotic SRP54 (both mammalian and yeast) and Ffh. A second pool contained the reverse complements of sequences encoding a seven amino acid stretch (designated B in Figure 1 ) that is conserved between SRa and FtsY, as well as SRP54 from mammals and yeast. We used PCR to amplify DNA products from genomic DNA of both Schizosaccharomyces pombe and S. cerevisiae using the two oligonucleotide pools as primers. Because the spacing between regions A and B is conserved between mammalian SRa and FtsY, we predicted that amplification of the desired yeast genes would yield products of 110 bp. Indeed, both PCRs yielded abundant products of the expected size as part of a complex mixture. The 1 10-bp PCR products were purified by gel electrophoresis and sequenced directly as described (Hann et al., 1989 ) (see also MATERIALS AND METHODS and Figure 1 the expected orientation and reading frame (shaded in Figure 1 ) that were similar to the corresponding region of mammalian SRa and FtsY. Moreover, the amino acid sequences were distinct from known sequences of SRP54 in S. cerevisiae and S. pombe ( Figure 1 ). Figure  4A ). After low-speed centrifugation, SRa and Sec6lp were each equally distributed between the pellet fraction ( Figure 4A , lane 3) and the supematant fraction ( Figure  4A , lane 2). The presence of the two proteins in the low-speed pellet is presumably due to incomplete cell lysis. On further centrifugation at 100 000 X g, SRa and Sec6lp were quantitatively recovered in the pellet fraction ( Figure 4A , lane 5), suggesting that both proteins were associated with intracellular membranes.
The physical association of SRa with intracellular membranes was examined by extracting the low-speed supematant fraction with various reagents known to perturb protein-membrane interactions. After centrifugation of the extracts at 100 000 X g, supematant and pellet fractions were subjected to SDS-PAGE and immunoblotted with anti-SRa and anti-Sec61p ( Figure 4B ). SRa remained associated with the membrane fraction after treatment with 1.6 M urea ( Figure 4B , lanes 3 and 4) or high salt ( Figure 4B , lanes 5 and 6). In contrast, when membranes were disrupted with non-ionic detergent, most of SRa was released into the 100 000 X g supematant fraction (compare lanes 7 and 8). The presence of a portion of Sec61p in the 100 000 X g detergent pellet may be due to its association with other proteins in the ER that remain insoluble after detergent extraction.
To test whether SRa is an integral membrane protein, we diluted the low-speed supematant with a large excess of a solution of sodium carbonate at pH 11.5 and centrifuged as above. Under alkaline conditions peripheral, but not integral, membrane proteins are ex- 
Molecular Biology of the Cell S.C. Ogg et al. (Fujiki et al., 1982) . SRa was quantitatively recovered in the supematant fraction, whereas Sec61p remained in the pellet fraction ( Figure  4B , lanes 9 and 10). (Rothstein, 1983) . The entire coding region of SRP101 was replaced with a selectable marker, the ADE2 gene (schematically shown in Figure  5A ). In brief, we used a novel approach based on PCR to construct a linear DNA fragment containing the ADE2 gene flanked by DNA sequences derived from the 5' and 3' flanking regions of the SRP11 locus ( Figure 5A , PCR step). This DNA was introduced into diploid ade2-cells (strain W303) by transformation and selection of Ade+ colonies ( Figure 5A , gene replacement step). Integration of the ADE2 gene at the SRP101 locus was confirmed by PCR analysis ( Figure 5B , compare lanes 1 and 2). For this analysis, oligonucleotides corresponding to regions Y and Z in Figure 5A , which lie outside the regions of homology used for integration (W and X in Figure 5A) Figure 5B , lanes 1 and 2) yielded a predicted 2.4-kb PCR product. Integration of the ADE2 gene into the SRP11 locus (srplOl-Al) was revealed by the presence of a larger 3.0-kb PCR product ( Figure 5B , lane 2). The identity of these PCR products was confirmed by restriction analysis. Sporulation of diploid SOY34
(SRP101/srplO01-Al) cells produced tetrads containing two to four viable spores. PCR analysis of the four colonies produced from spores of a single tetrad confirmed that the deletion allele srplOl-Al cosegregated with the ADE2 gene ( Figure 5B ).
All SRP101 spores were Ade-, formed normal colonies on plates, and grew in culture with a doubling time similar to that of the parent W303 strain (-80 min). In Figure 2 . Alignment of the amino acid sequences of SRa homologues. The deduced amino acid sequence of mammalian SRa (canine; Lauffer et al., 1985) , S. cerevisiae SRa (this work), and FtsY (E. coli ; Gill et al., 1986) (Dayhoff et al., 1972) as described by Bernstein et al. (1989) and Hann et al. (1989) . Gaps are indicated with dashes. The positions of three regions matching GTP-binding consensus sequences are indicated above the alignment by roman numerals (Dever et al., 1987) . The amino acid sequence of the third conserved motif SKxD (box III) predicted to contact the guanine ring of GTP differs by a conservative substitution in S. cerevisiae SRa from the consensus TKxD defined for all other known members of the SRP54/SRa subfamily of GTPases. The beginning of the G-domain, as defined by Bernstein et al. (1989) , is marked. The primary structures of SRa homologues from two additional species are known but for clarity omitted from this alignment. These proteins are the products of the PilA gene from Neisseria gonorrhoeae (Taha et al., 1991) and the SSO gene from Sulfolobus solfataricus (Ramirez and Matheson, 1991) . As for E. coli FtsY and eukaryotic SRa, the primary structures of these proteins are very similar in the G-domain but diverge in N-terminal regions. 4) , 0.6 M KOAc (lanes 5 and 6), 0.5% Triton X-100 (lanes 7 and 8), or 0.1 M Na2CO3, pH 11.5 (lanes 9 and 10). The samples were centrifuged at 100 000 X g and the supernatant fractions (lanes 1, 3, 5, 7, and 9) and pellet fractions (lanes 2, 4, 6, 8, and 10) were analyzed by Western blot using affinity purified anti-SRa and anti-Sec6lp. Only the relevant portions of each immunoblot are shown. SRa was frequently observed as a doublet, presumably due to some proteolysis that occurred during cell fractionation. Note that no doublet was observed when cell extracts were prepared rapidly and under denaturing conditions (see Figure 3). Figure 5 . Gene disruption of SRP1I1. (A) The gene disruption procedure is depicted (see MATERIALS AND METHODS). Oligonucleotides composed of sequences from both the ADE2 gene and sequences from regions W and X of the SRP101 gene were used in a PCR reaction to generate a DNA fragment (PCR fragment) containing the ADE2 gene of S. cerevisiae flanked at either end by sequences from the 5' and 3' untranslated regions of the SRP101 locus. Upon transformation, the end sequences directed the integration of the linear DNA fragment into the SRPI1O gene (one-step gene replacement). PCR confirming the gene disruption was performed on yeast genomic DNA using the oligonucleotides corresponding to regions Y and Z. (B) PCR reactions confirming the gene disruption were performed on genomic DNA from the wild-type parent strain (lane 1), SOY34, the diploid transformant heterozygous for SRP101, and the srplOl:.ADE2 gene disruption (srplOl-Al; lane 2) or cells derived from the surviving spores of a single tetrad that are either Ade+ (lanes 5 and 6) or Ade-(lanes 3 and 4). The PCR products were separated on a 1% agarose gel and visualized by ethidium bromide staining. (C) Growth rates in YEPD medium of strains in which the chromosomal copies of SRP101, SCR1 (see MATERIALS AND METHODS), or both SCR1 and SRP101 have been disrupted. If SRP and SRa function in sequential steps of a common protein targeting pathway, then the absence of both SRP and SRa should be no more detrimental to cell growth than the absence of either component alone. To test this directly, we constructed strain SOY60 in which the SRP RNA gene was deleted (scrl-A2) and strain SOY62 in which the genes encoding SRP RNA and SRa were both deleted (srplOl-A1/scrl-A2). SOY60 and SOY62 were both constructed in the same strain background (W303) used elsewhere in this study. The results depicted in Figure 5C show that cells bearing the double gene deletion grow with a doubling time that is comparable with that of cells bearing either gene deletion alone.
Conditional Expression of SRa
To characterize the molecular nature of the defects in SRa deficient cells, we constructed a strain (SOY46) that allows the conditional expression of SRa. SOY46 is a haploid strain bearing the srplOl-Al deletion allele that is complemented by a plasmid (pS0400) containing SRP1O1 under control of the GALI promoter. SOY46 cells grew as well as wild-type cells when galactose was used as a carbon source ( Figure 6A , early time points). Under these conditions, the level of SRa was -50-fold higher than found in wild-type cells, as estimated from an immunoblot analysis using anti-SRa antibodies (Figure 6B, compare lanes 1 and 7) . The level of SRa decreased rapidly, when SOY46 cells were switched to growth medium containing glucose. After 16 h of growth on glucose containing medium, the amount of SRa was approximately equal to the amount found in wild-type cells ( Figure 6B, compare lanes 4 and 7) . By 19 h, SRa had fallen below wild-type levels and by 32 h was barely detectable by immunoblot analysis ( Figure  6B , lanes 5 and 6; also see Figure 1 1B, lane 1). Concomitant with the drop of SRa levels, SOY46 cells began to grow at a slower rate ( Figure 6A) monitored the maturation of several newly synthesized soluble and membrane proteins known to be translocated across the ER membrane. SOY46 cells were pulse labeled for 7 min with 35S-methionine at various time points after the repression of SRa synthesis. Cell extracts were prepared from the labeled cells, and individual proteins were immunoprecipitated with specific antibodies and analyzed by SDS-PAGE. This allowed us to monitor the efficiency with which different proteins were translocated into the ER. For all substrates analyzed, translocation across the ER is accompanied by well-characterized modifications (signal sequence cleavage and/or glycosylation) that alter their gel mobility. Figure 7 shows the results of such an analysis at time points during the course of SRa depletion. Under these conditions, four of the five proteins analyzed showed an accumulation of cytoplasmic precursor forms, indicating that protein translocation was perturbed as a consequence of the reduced SRa level. The degree to which translocation was affected, however, varied among the different proteins. KAR2p, a soluble ER resident protein, and DPAP-B, a vacuolar integral membrane protein, showed the greatest defect. In the case of KAR2p, the translocation defect is inferred from the accumulation of a more slowly migrating band representing preKAR2p, which contains the uncleaved signal sequence ( Figure 7B, lanes 2 and 3, preKAR2p) ; in the case of DPAP-B, the defect is inferred from the accumulation of a faster migrating band representing unglycosylated DPAP-B ( Figure 7A , lanes 2 and 3, preDPAP-B). At the later time point, 20 or 21 h after repressing the synthesis of SRa, about one half of the KAR2p or DPAP-B synthesized remained untranslocated. The translocation of invertase and prepro-a-factor were affected to a lesser extent, but for both proteins significant amounts of precursor forms (Figure 7 , C, lanes 2 and 3, prelnv, and D, lanes 2 and 3, ppaF) accumulated after repression of SRa synthesis. In contrast to the four translocation substrates discussed above, CPY showed no detectable translocation defect on SRa depletion as indicated by the absence of a band migrating in the position of its cytoplasmic unglycosylated prepro-form (Figure 7E, ppCPY) . No effect was observed on the translocation of any of the four substrates when an isogenic strain carrying SRP1O1 controlled by its own promoter was switched from galactose to glucose (Figure 7 , A, B, D, and E, wt lanes). Note that translocation defects were already apparent at the first timepoint in the analysis shown in Figure 7 , which was taken 10 h after switch of the SOY46 cells from galactose to glucose, yet at this time the intracellular SRa level as judged by Western analysis was still above that found in wild-type cells ( Figure 6B ). This apparent paradox can be reconciled if we assume that in SOY46 cells (which overproduce SRa from the GALl promoter) only a portion of the SRa is properly assembled at the membrane and functional, whereas another portion remains unassembled and nonfunctional. As discussed above, fractionation of SOY46 cells grown on galactose indicated that a large portion of SRa remained Figure 7 . Precursor protein accumulation on depletion of SRa. SOY46 cells (GALI promoter regulated SRP101) and SOY48 cells (wildtype SRP101) were grown as described in Figure 6A . Before (0 h Figure 8 . Accessibility of accumulated preKAR2p to protease. SOY46 cells (GALl promoter regulated SRPIOI) and SOY48 cells (wild-type SRPIOI) were grown as described in Figure 6 and pulse labeled at 20 h after the shift from galactose to glucose. Extracts were prepared under nondenaturing conditions (see MATERIALS AND METHODS) from SRa depleted (lanes 1-4) and wild-type cells (lanes 5-8) and either digested with 0.5 mg/ml proteinase K (PK) or mock digested in the presence (lanes 3, 4, 7, and 8) or absence (lanes 1, 2, 5, and 6) of 0.5% Triton X-100. After inactivation of the protease, immunoprecipitations were performed with anti-KAR2p antibodies, followed by SDS-PAGE. The accumulation of preKAR2p in the cytoplasm could be explained in two ways. First, cellular depletion of SRa could cause a kinetic delay in the targeting of preKAR2p to the ER membrane. The precursor observed after the pulse labeling would then represent an intermediate in the translocation process and would be expected eventually to reach the lumen of the ER. Alternatively, the depletion of SRa could impair the efficiency of targeting rather than the rate of the process, allowing only a portion of the nascent preproteins to become productively engaged with the translocation machinery. To distinguish between these possibilities, we performed a pulse-chase analysis. Both control and SOY46 cells were pulse labeled for 2 min with 35S-methionine 20 h after repressing the synthesis of SRa, followed by addition of a large excess of nonradioactive methionine. The forms of KAR2p were examined by immunoprecipitation at timepoints during a 16-min chase period. The results are presented in Figure 9 . From the quan-A in a cytoplasmic supernatant. Accordingly, upon SRa depletion, only a portion of the SRa remaining in the cells as detected in Figure 6B may be functional. Alternatively, SRa expression from SOY46 cells could be nonuniform during the depletion experiment, giving rise to cell populations that are heterogeneous with respect to their levels of SRa. At the 10-h timepoint then, there could exist a population of cells that contain higher than wild-type levels of SRa and show no translocation defect, in addition to a population of cells that contain lower than wild-type levels of SRa and show a defect in protein translocation. The Western blot shown in Figure 6B would not distinguish these two populations.
The data presented suggest that the SRa facilitates protein translocation across the membrane of the ER. Because translocation was assayed indirectly in the experiments shown in Figure 7 , we used a protease protection assay to ask whether the precursor proteins detected were retained in the cytoplasm or had, in fact, entered the ER. To this end, control cells or SOY46 cells (taken 20 h after SRa synthesis had been repressed), were pulse labeled, and crude cell extracts were prepared. The extracts were treated with proteinase K. PreKAR2p that was present in SOY46 cell extracts (Figure 8, lane 1, preKAR2p) but not in the control cell extracts (Figure 8 , lane 5) was completely digested by proteinase K (Figure 8, lane 2) . In contrast, mature KAR2p was resistant to proteolysis ( Figure 8 , lanes 2 and 6, KAR2p), presumably because it was sequestered within ER membrane vesicles. When membrane vesicles in the extract were disrupted with detergent, KAR2p became accessible to protease and was digested under these conditions (Figure 8, lanes 4 and 8) . Thus, we conclude that preKAR2p accumulated in the cytoplasm in SRa depleted cells. Figure 9 . Pulse-chase of preKAR2p after SRa depletion. Twenty hours after switch from galactose to glucose medium, SOY48 cells (wild-type SRP101) and SOY46 cells (GALl promoter regulated SRPIO1) were pulse labeled for 2 min with 35S-methionine and chased for 0, 1, 2, 4, 8, or 16 min after the addition of excess unlabeled methionine. (A) Extracts prepared from each time point were subjected to immunoprecipitation with anti-KAR2p antibodies, followed by SDS-PAGE and autoradiography. The position of mature KAR2p and preKAR2p are indicated. (B) The data in A were quantitated using a Phosphorimager (Molecular Dynamics, Sunnyvale, CA). Note that the percent translocation, as calculated from the ratio of preKAR2 and KAR2, was less in this experiment than during the corresponding SRa depletion experiments shown in Figure 7 . This is due to the longer pulse time used in Figure 7 , which allowed more preKAR2p to accumulate. titative analysis of the data ( Figure 9B ), it is apparent that most of the accumulated preKAR2p did not chase into the mature form during the chase period. These data suggest that the translocation defect observed after removal of SRa is not due to a kinetic delay but represents a reduction of the efficiency with which preproteins can be translocated. This analysis identifies two distinct pools of KAR2p: one portion that was translocated and processed to mature KAR2p during the time of the pulse and one portion, the accumulated preKAR2p, that was rendered translocation incompetent.
Cells can Adapt to the Absence of SRae and SRP
The defects in protein translocation demonstrated in Figures 7-9 were observed in cells in which SRa was progressively depleted after repression of its synthesis.
To determine the effects of long-term SRa depletion, we performed similar experiments to monitor translocation defects in srplOl-Al mutant cells. Surprisingly, we detected no translocation defects in srplOl-Al cells when 35S-methionine pulse-labeled extracts were immunoprecipitated with anti-KAR2 and anti-DPAP-B antibodies ( Figure 10 , lane 4). This result was unexpected because the corresponding experiment performed with yeast SRP, a component of the same pathway, showed only minor amelioration of translocation defects in deletion strains (Hann and Walter, 1991) . Because a different strain (TR1) was used in the previous study, we repeated the experiment with cells containing a deletion of the SRP RNA gene, SCR1, in the W303 strain background used in this study (SOY60) . In these cells and in cells containing the double deletion scrl-A2 and srplOl-Al (SOY62), translocation defects of both KAR2p and DPAP-B are barely detectable (Figure 10 , lanes 3 and 5).
Thus, it appears that W303 cells are capable of adapting efficiently to the absence of SRa. Translocation defects were observed when SRa was depleted from cells rapidly after shutoff of its synthesis yet were not apparent when cells bearing the genetic disruption of SRa were grown for a prolonged time in the absence of SRa. To show this adaptation directly, we grew SOY46 (SRP1O1 under control of the GALI promoter) for an extended time on plates containing glucose, i.e., under conditions that repress SRa synthesis from the GALl promoter. Analogous to the phenotype of srplOl-Al cells, neither preDPAP-B nor preKAR2p were detected above the level found in wild-type control cells (Figure  1 A) . Thus, the translocation defects that are maximal between 10 and 20 h after shutoff of SRa synthesis (Figure 7 , A and B, lanes 2 and 3) are no longer apparent after growth in the absence of SRa for a prolonged time. This reduction in the translocation defects was not due to increased SRa levels. Western blot analysis confirmed that the intracellular SRa level remained depressed even after prolonged growth on glucose plates (Figure 1lB , lane 3).
Curiously, although cells grown for prolonged time in the absence of SRa are able to diminish their apparent protein translocation defects, they do not increase their growth rate as a result of this adaptation (compare Figure 6A and 5C) .
To distinguish whether the adaptation was due to the accumulation of a simple suppressor mutation or was due to a reversible physiological change on SRa depletion, we performed a back cross experiment. Haploid SOY46 cells were grown on glucose plates to allow adaptation to occur. These cells were then mated with the strain SOY53 that, like SOY46, contains the chromosomal srplOl-Al deletion but a different plasmid (Felici et al., 1989; Hann and Walter, 1991) . Furthermore, we showed that mitochondrial precursor proteins accumulate in SRP-depleted cells (Hann and Walter, 1991 (Hann and Walter, 1991) . SOY46 (GALl promoter regulated SRP101), SOY48 (wild-type SRP1I01), and MYY147 (masl-l) cells were grown and labeled as described in Figure 7 . Cell extracts were subjected to immunoprecipitation with antibodies to the ,B-subunit of the F1 ATPase, followed by SDS-PAGE.
Precursor (Lauffer et al., 1985) . (Walter and Blobel, 1981) . These in vitro studies led to the notion that SRa is required for releasing SRP-induced translational arrest. In the absence of SRa, protein synthesis would not proceed beyond a short "arrested fragment" of the presecretory protein.
To date, such a tight arrest has only been observed in in vitro assays composed of heterologous components, e.g., mammalian SRP and a wheat germ translation system. In assays composed of exclusively mammalian components, the SRP-induced elongation arrest is transient, thus causing a kinetic delay in protein elongation (Wolin and Walter, 1989) . We previously have speculated that the effects of SRP on presecretory protein synthesis may help to maintain proteins in a translocation competent state and/or may provide a potential regulatory point to couple translation to the secretory needs of the cell.
In the experiments described here, presecretory protein synthesis is not detectably reduced as compared with overall protein synthesis when SRa is depleted from cells. We therefore conclude that the lack of SRP receptor in vivo does not lead to a tight elongation arrest that is not released in the absence of SRa. In future studies, it will be interesting to measure directly the elongation rates of presecretory protein synthesis in SRa-depleted cells to test whether yeast SRP causes elongation pausing in vivo as observed in the mammalian in vitro system. Interestingly, in a different yeast, Yarrowia lipolytica, it recently was shown that mutations in SRP RNA can cause an inhibition of the translation of a secretory protein (He et al., 1992; Yaver et al., 1992) .
Functional Role of Yeast SRa in ER Targeting
From previous studies of SRP, we concluded that in yeast, protein targeting to the ER can occur by redundant pathways (Hann and Walter, 1991) . The data presented here for the SRP receptor confirm this notion. In the absence of SRP and SRP receptor, proteins must be targeted to and translocated across the ER membrane by alternative SRP and SRP receptor independent targeting pathways. Although the translocation of some proteins is severely impaired on disruption of the SRP/SRP receptor dependent targeting pathway, the mutant cells are viable. Thus, every protein that has to cross the ER membrane during its biogenesis and that is essential for cell viability can use an alternate targeting pathway sufficiently well to sustain cell growth.
Most of the proteins analyzed were impaired in their translocation across the ER membrane in SRP and/or SRP receptor depleted cells. We consider it likely that these proteins are cotranslationally targeted by SRP and SRP receptor to the ER membrane in wild-type cells and that they become rerouted into alternative targeting pathways only in the mutant cells lacking SRP and/or SRP receptor function. Some preproteins, e.g., preproCPY, that can be targeted as efficiently in the absence of SRP as in its presence may have evolved signal sequences that do not interact efficiently with SRP. Thus, preproCPY may not use the SRP dependent targeting pathway even in wild-type cells (Bird et al., 1987; Hann and Walter, 1991 According to a second hypothesis, SRP/SRP receptor independent targeting could occur cotranslationally; ribosomes synthesizing precursor proteins engage with the ER membrane independent of SRP and SRP receptor but before termination of protein synthesis. If cotranslational targeting is obligate for a given precursor protein, then the kinetics of its elongation would affect the efficiency of its membrane translocation. If elongation is slow, for example, then a longer time window would be available for the nascent precursor protein to engage with the ER membrane before it is completed and released from the ribosome.
The pulse-chase data in Figure 9 show that in SRadepleted cells, the accumulated pool of cytosolic preKAR2p molecules is not translocation competent. Although we cannot rule out that some of these preKAR2p molecules are translocated very slowly, such slow kinetics could not account for the rapid appearance of translocated KAR2p at the earliest time point. Similar kinetic data were previously obtained in SRP-depleted cells (Hann and Walter, 1991) . These data are consistent with either model outlined above. The observed translocation of preKAR2p may occur by a rapid posttranslational mechanism, and a factor mediating this reaction may be limiting. Therefore, only a portion of the precursor proteins would be able to interact with this factor and be translocated. The other portion would be rapidly rendered translocation incompetent. Alternatively, it is possible that preKAR2p requires cotranslational targeting and cannot be maintained translocation competent if released from the ribosome. In this case, the translocated portion of the KAR2p molecules would be synthesized exclusively by ribosomes that are engaged with the ER membrane during KAR2p synthesis.
Growth and translocation defects of SRa-depleted cells resemble those observed in SRP-depleted cells (Hann and Walter, 1991) . After shutoff of SRa or SRP54 synthesis, the translocation of KAR2p and DPAP-B was severely impaired, the translocation of invertase and pro-a-factor showed intermediate defects, and the translocation of preproCPY was not affected. There are some quantitative differences in the relative magnitudes of the translocation defects. The translocation of DPAP-B, for example, was impaired to >90% in SRP-depleted cells (Hann and Walter, 1991) , yet only impaired to -50% in SRa-depleted cells (Figure 7 ). Most likely these differences arose because different strains were used in these studies.
Cells that have been grown in the absence of SRP or SRP receptor for a prolonged time "adapt" to the lack of these components. In the W303 strain used in this study, the adaptation results in almost undetectable translocation defects among the preproteins examined.
In the TR1 strain used previously (Hann and Walter, 1991) , a similar adaptation was observed that was less pronounced. SRa-depleted cells in which translocation defects are no longer detectable grow with a sixfold increased doubling time, indicating that the adaptation process cannot restore cell physiology to a wild-type state. The molecular nature of the adaptation process is presently unknown. From the presented data, we can rule out, however, that the adaptation is a direct consequence of a suppressor mutation or of the rho-phenotype that cells acquire after growth in the absence of SRa. According to the two models discussed above, translocation in adapted cells could be enhanced either because limiting components mediating alternate targeting pathways are induced and/or because the rate of protein elongation is reduced. The latter possibility would provide a plausible mechanism by which translocation can be improved but cell growth remains impaired. More efficient protein translocation would be obtained at the expense of efficient protein synthesis. Further studies of the molecular nature of the adaptation process are required to distinguish between these possibilities and may provide valuable information as to the mechanism of SRP/SRP receptor independent protein targeting. From the available data, it is still conceivable that the efficiency of protein translocation only appears to be improved in adapted cells. Cells may have improved a "housekeeping" pathway that allows mislocalized precursor proteins to be degraded more rapidly. This would change the precursor to product ratio that presently is the only measure for translocation efficiency. Surprisingly, the import of the f-subunit of the F1-ATPase (Flo) into mitochondria was impaired in SRadepleted cells. A similar phenotype was observed in SRP-depleted cells. As discussed previously (Hann and Walter, 1991) , the impaired mitochondrial import could be an indirect consequence of cumulative defects in cells after disruption of the SRP/SRP receptor dependent targeting pathway. Alternatively, it remains possible that SRP and SRa are directly involved in mitochondrial protein import. Models entertaining this latter notion would need to explain, however, how SRa, which is thought to be restricted in its intracellular localization to the ER membrane, could also participate in mitochondrial import. At present, the available data do not allow us to distinguish conclusively between different possibilities. On SRa or SRP depletion, cells rapidly acquired a rho-phenotype (see RESULTS; Felici et al., 1989; Hann and Walter, 1991) . This loss of mitochondrial function could be a direct consequence of the impaired protein import.
